Search

Insulet Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

138.86 4.71

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

130

Max

139.41

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-11M

91M

Pardavimai

-22M

762M

P/E

Sektoriaus vid.

39.65

68.51

Pelnas, tenkantis vienai akcijai

1.42

Pelno marža

11.96

Darbuotojai

5,400

EBITDA

-23M

154M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+30.91% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-117M

12B

Ankstesnė atidarymo kaina

134.15

Ankstesnė uždarymo kaina

138.86

Naujienos nuotaikos

By Acuity

74%

26%

310 / 340 reitingas Healthcare

Insulet Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-06 23:32; UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

2026-08-05 23:46; UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

2026-08-04 23:56; UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

2026-08-03 19:36; UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

2026-07-31 20:06; UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

2026-07-29 18:43; UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

2026-07-28 19:06; UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

2026-07-27 20:06; UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

2026-07-24 22:26; UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

2026-07-22 20:01; UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

2026-07-20 18:36; UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Akcijų palyginimas

Kainos pokytis

Insulet Corp Prognozė

Kainos tikslas

By TipRanks

30.91% į viršų

12 mėnesių prognozė

Vidutinis 174.45 USD  30.91%

Aukščiausias 216 USD

Žemiausias 144 USD

Remiantis 23 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Insulet Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

23 ratings

13

Pirkti

9

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

310 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat